These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15145135)

  • 1. [Treatment of intrastent restenosis].
    Eltchaninoff H; Tron C; Sebagh L; Cribier A
    Pathol Biol (Paris); 2004 May; 52(4):218-22. PubMed ID: 15145135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy.
    Zavalloni D; Rossi M; Belli G; Scatturin M; Morenghi E; Marsico F; Catalano G; Tosi G; Pagnotta P; Presbitero P
    J Invasive Cardiol; 2005 Nov; 17(11):598-602. PubMed ID: 16264205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis.
    Fasseas P; Orford JL; Lennon R; O'Neill J; Denktas AE; Panetta CJ; Berger PB; Holmes DR
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):152-7. PubMed ID: 15390249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis.
    Bagga R; Kini A; Lee P; Agarwal A; Duffy M; Kim M; Sharma S
    J Invasive Cardiol; 2005 Jun; 17(6):302-6. PubMed ID: 16003004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
    Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
    J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis.
    Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular brachytherapy for patients with drug-eluting stent restenosis.
    Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?
    Ruef J; Hofmann M; Störger H; Haase J
    Cardiovasc Revasc Med; 2007; 8(3):170-4. PubMed ID: 17765646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
    Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
    J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restenosis treatment in the drug-eluting stent era.
    Presbitero P; Boccuzzi G
    Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.
    Alfonso F; Melgares R; Mainar V; Lezaún R; Vázquez N; Tascón J; Pomar F; Cequier A; Angel J; Pérez-Vizcayno MJ; Sabaté M; Bañuelos C; Fernández C; García JM;
    Eur Heart J; 2004 Oct; 25(20):1829-35. PubMed ID: 15474698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debulking for in-stent restenosis in the brachytherapy era: does it still have a role?
    Tuli A; Subramaniyam V; Bakir S; Block PC; Crocker IR
    J Invasive Cardiol; 2003 Apr; 15(4):209-12. PubMed ID: 12668849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study.
    Alfonso F; Augé JM; Zueco J; Bethencourt A; López-Mínguez JR; Hernández JM; Bullones JA; Calvo I; Esplugas E; Pérez-Vizcayno MJ; Moreno R; Fernández C; Hernández R; Gama-Ribeiro V;
    J Am Coll Cardiol; 2005 Sep; 46(5):756-60. PubMed ID: 16139121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-eluting stents and other anti-restenosis devices].
    Moreno R
    Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.